Researchers at Illinois Institute of Technology in the US have developed a new collagen-based membrane for use in organs-on-chips to allow better diagnosis and treatment of digestive conditions.
Claimed to be more natural than existing products, the new membrane is expected to allow microchips to better mimic the way healthy intestinal cells become diseased or respond to drugs.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Organ-on-a-chip devices usually consist of a porous membrane surrounded by two flexible, translucent polymers or plastics.
Researchers believe that the commonly used plastic membranes could disturb interactions between cells, which are obtained from a human organ and grown on the polymer or the membrane.
They expect that the newly developed more natural membrane will facilitate normal cell growth and development.
In order to validate the new membrane, the team compared three separate microfluidic devices, with one plastic-derived membrane, one from collagen, and one membrane-free.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataResearchers observed that five days after the implantation of human colon cells into each device, cells on the collagen-based membrane were more viable compared to those in the remaining two devices.
Furthermore, cells grown on the natural membrane were found to be more distinctive and better integrated with collagen fibres, altering the microenvironment.
Based on these findings, the team concluded that use of collagen-based membranes in organ-on-a-chip devices will increase growth, viability and barrier function of human colon cells.
They also hope to observe similar effect on cells from other organs.
